Didar Yanardağ Açık

6PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Analytical spectrometryCancer therapy (excl. chemotherapy and radiation therapy)HaematologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Frontline ABVD Remains an Effective Option in Advanced-Stage Classical Hodgkin Lymphoma: Real-World Data from Turkey.

|Nov 03, 2025
Dimethylsulfoxide-Associated Anaphylaxis in Autologous Stem Cell Transplantation: A Case Report.

Didar Yanardag Acik, Elif Suyani, Bilal Aygun

|Sep 13, 2021
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.

Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden

|Sep 28, 2020
Can the neutrophil-lymphocyte ratio predict type 1 hereditary angioedema attacks?

Guzin Ozden, Didar Yanardag Acik

|Nov 14, 2019
Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia?

Didar Yanardag Acik, Mehmet Bankir, Filiz Alkan Baylan

|May 22, 2019
Recognizing the unusual findings: Cases of desiderosmia.

Didar Yanardag Acik

Pageof 1

Frequent Collaborators

2 joint publications

Nurhilal Buyukkurt

1 joint publications

Guzin Ozden

1 joint publications

Elif Suyani

1 joint publications

Bilal Aygun